Cargando…

Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients

Children and youth infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have milder disease than do adults, and even among those with the recently described multisystem inflammatory syndrome, mortality is rare. The reasons for the differences in clinical manifestations are unkn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pierce, Carl A., Preston-Hurlburt, Paula, Dai, Yile, Aschner, Clare Burn, Cheshenko, Natalia, Galen, Benjamin, Garforth, Scott J., Herrera, Natalia G., Jangra, Rohit K., Morano, Nicholas C., Orner, Erika, Sy, Sharlene, Chandran, Kartik, Dziura, James, Almo, Steven C., Ring, Aaron, Keller, Marla J., Herold, Kevan C., Herold, Betsy C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658796/ https://www.ncbi.nlm.nih.gov/pubmed/32958614 http://dx.doi.org/10.1126/scitranslmed.abd5487

Ejemplares similares

Natural mucosal barriers and COVID-19 in children
por: Pierce, Carl A., et al.
Publicado: (2021)

Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2
por: Cheshenko, Natalia, et al.
Publicado: (2022)

Author Correction: Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2
por: Cheshenko, Natalia, et al.
Publicado: (2023)

Herpes simplex viruses activate phospholipid scramblase to redistribute phosphatidylserines and Akt to the outer leaflet of the plasma membrane and promote viral entry
por: Cheshenko, Natalia, et al.
Publicado: (2018)

HSV-2 triggers upregulation of MALAT1 in CD4(+) T cells and promotes HIV latency reversal
por: Pierce, Carl A., et al.
Publicado: (2023)

Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
por: Burn Aschner, Clare, et al.
Publicado: (2020)

A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023)

Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity
por: Burn Aschner, Clare, et al.
Publicado: (2020)

HSV Usurps Eukaryotic Initiation Factor 3 Subunit M for Viral Protein Translation: Novel Prevention Target
por: Cheshenko, Natalia, et al.
Publicado: (2010)

Herpes simplex virus triggers activation of calcium-signaling pathways
por: Cheshenko, Natalia, et al.
Publicado: (2003)

Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
por: Mahant, Aakash Mahant, et al.
Publicado: (2023)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling
por: Reed, James C., et al.
Publicado: (2020)

The Receptor for Advanced Glycation End Products (RAGE) Affects T Cell Differentiation in OVA Induced Asthma
por: Akirav, Eitan M., et al.
Publicado: (2014)

Bridging the Gap between Preclinical and Clinical Microbicide Trials: Blind Evaluation of Candidate Gels in Murine Models of Efficacy and Safety
por: Segarra, Theodore J., et al.
Publicado: (2011)

RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses
por: Akirav, Eitan M., et al.
Publicado: (2012)

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease
por: Petro, Christopher, et al.
Publicado: (2015)

Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation
por: Ablamunits, Vitaly, et al.
Publicado: (2012)

Maternal Immunization with a Single-Cycle Herpes Simplex Virus (HSV) Candidate Vaccine, ΔgD-2, Protects Neonatal Mice from Lethal Viral Challenge
por: Kao, Carol, et al.
Publicado: (2017)

Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza
por: Lu, Justin Y., et al.
Publicado: (2023)

SARS-CoV-2 multi-antigen protein microarray for detailed characterization of antibody responses in COVID-19 patients
por: Celikgil, Alev, et al.
Publicado: (2023)

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
por: Herold, Betsy C
Publicado: (2006)

A naturally occurring antiviral ribonucleotide encoded by the human genome
por: Gizzi, Anthony S., et al.
Publicado: (2018)

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes
por: Lasso, Gorka, et al.
Publicado: (2022)

Molecular Mechanisms Linking High Dose Medroxyprogesterone with HIV-1 Risk
por: Irvin, Susan C., et al.
Publicado: (2015)

Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis
por: Visciano, Maria Luisa, et al.
Publicado: (2021)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
por: Nelson, Cody S., et al.
Publicado: (2018)

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges
por: Ghazi, Tara, et al.
Publicado: (2014)

Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor
por: Morano, Nicholas C., et al.
Publicado: (2022)

Two Point Mutations in Old World Hantavirus Glycoproteins Afford the Generation of Highly Infectious Recombinant Vesicular Stomatitis Virus Vectors
por: Slough, Megan M., et al.
Publicado: (2019)

Phase I Randomized Safety Study of Twice Daily Dosing of Acidform Vaginal Gel: Candidate Antimicrobial Contraceptive
por: Keller, Marla J., et al.
Publicado: (2012)

Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING
por: Holm, Christian K, et al.
Publicado: (2012)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Inducing and Administering Tregs to Treat Human Disease
por: Perdigoto, Ana Luisa, et al.
Publicado: (2016)

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes
por: Sims, Emily K., et al.
Publicado: (2021)

Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by In Situ Proximity Ligation
por: Mittler, Eva, et al.
Publicado: (2021)

Under-utilization of Narrow-Spectrum Antibiotics in the Ambulatory Management of Pediatric UTI: A Single-Center Experience
por: Lee, Philip, et al.
Publicado: (2021)

RAGE: Exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenes
por: Clynes, Raphael, et al.
Publicado: (2007)

Bell’s palsy and lip HSV-1 infection: importance of subcutaneous access
por: Boukhvalova, Marina S, et al.
Publicado: (2022)

Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts
por: Bortz, Robert H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_shnsemgf9ua9f4j8ar9tej2ocv